Results 151 to 160 of about 29,631 (205)

Prevention of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines

New England Journal of Medicine, 2021
Mark G, Thompson, Lauren, Grant, Jennifer, Meece   +2 more
openaire   +5 more sources

Safety and Immunogenicity of a Fourth Dose of Omicron BA.1-Adapted BNT162b2 COVID-19 Vaccines in Adults 18-55 Years Old. [PDF]

Clin Infect Dis
Winokur P, Diya O, Fitz-Patrick D, Dever M, Gayed J, Lockhart S, Xu X, Zhang Y, Bangad V, Wadsworth LT, Cannon K, Cardona JF, Usdan L, Ginis J, Mensa FJ, Zou J, Xie X, Lu C, Buitrago S, Scully IL, Cooper D, Koury K, Jansen KU, Türeci Ö, Şahin U, Swanson KA, Gruber WC, Kitchin N.   +27 more
europepmc   +1 more source

Absence of autoantibodies linked to cancer and autoimmune disorders 26 weeks after BNT162b2 boosting in CoronaVac- primed individuals. [PDF]

Hum Vaccin Immunother
Mat Yassim AS, Mohd Hisham AA, Mohd Rosdan BS, Tan TM, Anuar ND, Mohamed Hashim EK, Norazmi MN.   +6 more
europepmc   +1 more source

BNT162b2 2024-2025 Vaccine Effectiveness Against COVID-19 in Children Aged 6 Months-17 Years. [PDF]

J Pediatric Infect Dis Soc
Tartof SY, Ahi T, Frankland TB, Slezak JM, Zamparo JM, Ackerson BK, Puzniak L.   +6 more
europepmc   +1 more source

Potential Public Health and Economic Impact of the Next-Generation COVID-19 Vaccine mRNA-1283 in The Netherlands. [PDF]

Vaccines (Basel)
van der Pol S, Beck E, Westra T, Postma M, Boersma C.   +4 more
europepmc   +1 more source

Long-Term Durability and Dynamics of Anti-S-RBD IgG Response in Healthcare Workers: A Comparative Analysis of Homologous and Heterologous SARS-CoV-2 Vaccination Schedules in a 1-Year Serial Cross-Sectional Study. [PDF]

Med Sci Monit
Demirel Ç, Kibar F, Dağlıoğlu G, Çetiner S, Candevir A, İnal AS, Yücel Karakaya SP, Görüroğlu Öztürk Ö, Gümüş HH, İnal TC.   +9 more
europepmc   +1 more source

Correction: Boikos et al. Co-Administration of BNT162b2 COVID-19 and Influenza Vaccines in Adults: A Global Systematic Review. <i>Vaccines</i> 2025, <i>13</i>, 381. [PDF]

Vaccines (Basel)
Boikos C, Schaible K, Nunez-Gonzalez S, Welch V, Hu T, Kyaw MH, Choi LE, Kamar J, Goebe H, McLaughlin J.   +9 more
europepmc   +1 more source

Post-vaccination SARS-CoV-2 infections and antibody responses after BNT162b2 in patients with severe obesity: a retrospective cohort study. [PDF]

Front Endocrinol (Lausanne)
Kara Z, Ak T, Demir AN, Akçin R, Dinç HÖ, Taşkın HE, Gareayaghi N, Kocazeybek B, Yumuk VD.   +8 more
europepmc   +1 more source

Four doses of coronavirus disease 2019 vaccination for patients with inborn errors of immunity compared to 3 doses for healthy individuals. [PDF]

J Allergy Clin Immunol Glob
Chan JCH, Cheng SMS, Leung D, Wang X, Wang M, Cheuk YC, Ho C, Tsang LCH, Kwan TC, Lee AMT, Li WY, Lam JHY, Zhang K, Tam IYS, Chan SM, Chan KW, Peiris M, Tu W, Lau YL, Rosa Duque JS.   +19 more
europepmc   +1 more source

Long-term kinetics of anti-RBD IgG antibodies 16 months after COVID-19 vaccination in Morocco: a longitudinal cohort study. [PDF]

Sci Rep
Abbadi I, Sarih M, Majidi H, Redwane S, Batcho S, Abounouh K, Aqillouch S, Bouddahab O, Hilmi S, Ainahi A, Tajudeen R, Fallah MP, Kaseya J, Maaroufi A, Ezzikouri S.   +14 more
europepmc   +1 more source